ロード中...
The progress of targeted therapy in advanced gastric cancer
Although palliative chemotherapy has been shown to prolong survival and improve quality of life, the survival of advanced gastric cancer (AGC) patients remains poor. With the advent of targeted therapy, many molecular targeted agents have been evaluated in clinical studies. Trastuzumab, an anti-HER2...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3878836/ https://ncbi.nlm.nih.gov/pubmed/24330856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-32 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|